Literature DB >> 15266776

Caudal regression syndrome and sirenomelia in only one twin in two diabetic pregnancies.

E Assimakopoulos1, A Athanasiadis, M Zafrakas, K Dragoumis, J Bontis.   

Abstract

Many authors consider sirenomelia to be an extreme form of caudal regression syndrome (CRS), while others argue that they are two distinct entities. Maternal diabetes mellitus is considered to be an important predisposing factor for both CRS and sirenomelia. Two rare cases of diabetic, dizygotic twin pregnancies, each with one normal and one affected fetus are presented. In case 1 the affected fetus had CRS. In case 2 the affected fetus had sirenomelia. The present cases suggest that the pathogenesis of CRS and sirenomelia is more complex than previously thought, that maternal diabetes is not the only underlying pathogenetic mechanism and that genetic or epigenetic factors probably contribute to the formation of these conditions.

Entities:  

Mesh:

Year:  2004        PMID: 15266776

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  4 in total

Review 1.  A clinical and experimental overview of sirenomelia: insight into the mechanisms of congenital limb malformations.

Authors:  Carlos Garrido-Allepuz; Endika Haro; Domingo González-Lamuño; María Luisa Martínez-Frías; Federica Bertocchini; Maria A Ros
Journal:  Dis Model Mech       Date:  2011-04-18       Impact factor: 5.758

2.  Sirenomelia in a Nigerian triplet: a case report.

Authors:  Rosemary O Ugwu; Augusta U Eneh; Woroma Wonodi
Journal:  J Med Case Rep       Date:  2011-09-02

Review 3.  Sirenomelia in twin pregnancy: A case report and literature review.

Authors:  Tingting Xu; Xiaodong Wang; Hong Luo; Haiyan Yu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

4.  Dichorionic twin pregnancy with sirenomelia and chromosomal anomaly in 1 fetus: A case report.

Authors:  Yuan Ting; Li Xue-Lan; Wang Chun-Bao; Zhang Ting; Li Fen; Han Zhen
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.